Radiation Puts Dialysis Patients at Higher Cancer Risk
HealthDay News - Younger patients and those on transplant list receive highest doses of imaging-related radiation
HealthDay News - Many dialysis patients are exposed to high levels of radiation because of frequent medical imaging procedures, putting them at increased risk of cancer, according to a study published online Feb. 25 in the Journal of the American Society of Nephrology.
Andreana De Mauri, MD, of University Hospital "Maggiore della Carita" in Novara, Italy, and colleagues investigated the cumulative radiation exposure in a group of dialysis patients. The researchers retrospectively reviewed medical records of 106 hemodialysis patients for a median of three years, collecting information about the number and type of radiology procedures they underwent. They then calculated the individual cumulative effective doses (CEDs) of radiation.
The researchers found that 22 patients received low doses of radiation each year, 51 received moderate doses, 22 received high doses, and 11 received very high doses. A total of 17 patients had a CED associated with a substantially increased risk of cancer-related death (>100 mSv). An increased CED was significantly associated with younger patients and patients awaiting transplant. Seventy-six percent of the total CED was due to CT scans.
"This study showed that within three years, a significant fraction of surviving hemodialysis patients received estimated radiation doses that may put them at an increased risk of cancer," the authors write. "These findings emphasize the need to begin tracking at least the computed tomography-related exposure, as recently suggested by the American College of Radiology, to develop and implement alternative strategies to reduce patient-specific radiation burden."
AbstractFull Text (subscription or payment may be required)
Copyright © 2011HealthDay. All rights reserved.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
